Carri DUNCAN

Non-executive Director

Founder, Karaktero Capital (2018-Present)

§Expert in Capital Markets Advisory, acting as an advisor and partner to Investors, Founders, CXOs and Boards
 

VP, Corporate Development, Celyad Oncology (2018-2018)

Investor relations, Bayer (2014-2018) 

Consultant, Egon Zehnder (2011-2014) 

Healthcare Analyst, Macquarie (2008-2011)

Buy-side Equity Analyst, Credit Suisse (2006-2008)

Research Scientist, Novartis (2003-2006)

eureKING

128 rue de la Boétie, 75008 Paris, France

info@eureKING.com

Press Contacts

 

Nicolas Merigeau

+33 (0)1 44 71 94 98 

nmerigeau@newcap.fr 

Arthur Rouillé

+33 (0)1 44 71 00 15

arouille@newcap.fr